Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2010
10/21/2010US20100269203 Plants and seeds of hybrid corn variety ch414517
10/21/2010US20100269202 Plants and seeds of hybrid corn variety ch651588
10/21/2010US20100269201 Plants and seeds of hybrid corn variety ch088316
10/21/2010US20100269200 Plants and seeds of hybrid corn variety ch997005
10/21/2010US20100269199 Plants and seeds of hybrid corn variety ch794019
10/21/2010US20100269198 Plants and seeds of hybrid corn variety ch550494
10/21/2010US20100269197 Plants and seeds of hybrid corn variety ch134921
10/21/2010US20100269196 Plants and seeds of hybrid corn variety ch475849
10/21/2010US20100269195 Plants and seeds of hybrid corn variety ch482178
10/21/2010US20100269192 Plants and seeds of corn variety cv589782
10/21/2010US20100269191 Plants and seeds of corn variety cv338423
10/21/2010US20100269190 Plants and seeds of corn variety cv897903
10/21/2010US20100269186 Soybean variety xb25z09
10/21/2010US20100269184 Apo-2DcR
10/21/2010US20100269182 Lexa-based chemical-inducible gene expression system for use in transgenic animals
10/21/2010US20100267936 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES
10/21/2010US20100267931 Heterologous expression of neisserial proteins
10/21/2010US20100267930 SLO2 and SLO4, Novel Potassium Channel Proteins from Human Brain
10/21/2010US20100267929 PRRS Viruses, Infectious Clones, Mutants Thereof, and Methods of Use
10/21/2010US20100267816 Human anti-amyloid beta peptide antibody and fragment of said antibody
10/21/2010US20100267814 Targeting MicroRNAs for the Treatment of Liver Cancer
10/21/2010US20100267813 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
10/21/2010US20100267811 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
10/21/2010US20100267810 Methods and compositions for treating neurological disease
10/21/2010US20100267809 Double stranded nucleic acid targeting low copy promoter-specific rna
10/21/2010US20100267808 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
10/21/2010US20100267805 Targeting opposite strand replication intermediates of single-stranded viruses by rnai
10/21/2010US20100267802 Delivery method
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267649 Vascular adhesion molecules and modulation of their function
10/21/2010US20100267648 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/21/2010US20100267647 Modulating photoreactivity in a cell
10/21/2010US20100267646 Trophic Factor for the Treatment of Retinal Degenerative Diseases
10/21/2010US20100267623 Peptides with capacity to bind to scurfin and applications
10/21/2010US20100267618 Methods for treating congestive heart failure
10/21/2010US20100267587 siRNA targeting cyclin dependent kinase 11 (CDK11)
10/21/2010US20100267586 siRNA targeting KRAS
10/21/2010US20100267147 Site-directed mutagenesis in circular methylated dna
10/21/2010US20100267146 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
10/21/2010US20100267145 Immunocompetent cell having anti-cd38 antibody on its cell surface
10/21/2010US20100267140 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/21/2010US20100267139 Osteopontin nanoparticle system for drug delivery
10/21/2010US20100267133 Acrtiib-fc polynucleotides, polypeptides, and compositions
10/21/2010US20100267130 Chlamydomonas Intraflagellar Transport 88 (IFT-88)
10/21/2010US20100267129 Chimeric nucleic acids encoding polypeptides comprising domains of tnf family ligands
10/21/2010US20100267128 Compositions and method for use in isolation of nucleic acid molecules
10/21/2010US20100267121 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates
10/21/2010US20100267120 Recombinational cloning using nucleic acids having recombination sites
10/21/2010US20100267119 Recombinational cloning using nucleic acids having recombination sites
10/21/2010US20100267118 Recombinational cloning using nucleic acids having recombination sites
10/21/2010US20100267116 Filovirus vectors and noninfectious filovirus-based particles
10/21/2010US20100267115 Production of 3-hydroxypropionic acid using beta-alanine/pyruvate aminotransferase
10/21/2010US20100267112 Use of pks 13 protein coding for condensase of mycolic acids of mycobacteria and related strains as an antibiotics target
10/21/2010US20100267111 Polypeptide having hadh dependent hmf reductase activity
10/21/2010US20100267110 Laccases, nucleic acids encoding them and methods for making and using them
10/21/2010US20100267106 Method and circuit arrangement for treating biomaterial
10/21/2010US20100267095 Escherichia coli strains which over-produce l-threonine and processes for the production of l-threonine by fermentation
10/21/2010US20100267093 Enhanced homologous recombination mediated by lambda recombination proteins
10/21/2010US20100267088 Inha promoters
10/21/2010US20100267087 MUTANT PYRROLYSYL-tRNA SYNTHETASE, AND METHOD FOR PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN BY USING THE SAME
10/21/2010US20100267086 Optimized Nucleic Acid Sequences For The Expression of VB4-845
10/21/2010US20100267084 Protein glycosylation modification in methylotrophic yeast
10/21/2010US20100267083 Modified Cytochrome P450 Monooxygenases
10/21/2010US20100267082 Novel peptide-forming enzyme gene
10/21/2010US20100267072 Formation/Elongation of Axon by Inhibiting the Expression or Function of Singar and Application to Nerve Regeneration
10/21/2010US20100267053 Akt3 polypeptides
10/21/2010US20100267046 Isoform-selective inhibitor and activators of pde3 cyclic nucleotide phosphodiesterases
10/21/2010US20100267027 Her-2 binding antagonists
10/21/2010US20100267022 Monocyte-derived nucleic acids and related compositions and methods
10/21/2010US20100267016 Transgenic microbial polyhydroxyalkanoate producers
10/21/2010US20100266721 Debaryomyces castellii phytase
10/21/2010US20100266698 Use of insulin for the treatment of cartilaginous disorders
10/21/2010US20100266686 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/21/2010US20100266680 Treatment of Cancer Using TLR3 Agonists
10/21/2010US20100266673 Compositions and methods for the delivery of nitric oxide
10/21/2010US20100266639 Expression system
10/21/2010US20100266633 Aids virus vaccines using sendai virus vector
10/21/2010US20100266631 Compositions and Methods for Generating an Immune Response Utilizing Alphavirus-Based Vector Systems
10/21/2010US20100266630 Recombinant MVA virus, and the use thereof
10/21/2010US20100266627 Allelic exchange mutagenesis in map
10/21/2010US20100266624 Hepatitis-c virus testing
10/21/2010US20100266619 Neutralizing Antibodies and Methods of Use Thereof
10/21/2010US20100266617 Antibodies to human programmed death receptor pd-1
10/21/2010US20100266616 Polypeptides, antibody variable domains and antagonists
10/21/2010US20100266613 Anti-tnf-alpha antibodies and their uses
10/21/2010US20100266612 Bmp-alk3 antagonists and uses for promoting bone growth
10/21/2010US20100266609 Antibody Molecules Which Bind IL-17A and IL-17F
10/21/2010US20100266601 Antibodies that inhibit tslp activity
10/21/2010US20100266599 Human receptor proteins; related reagents and methods
10/21/2010US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
10/21/2010US20100266580 Translocation and mutant tnk1 kinase in human lymphoma
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266575 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING
10/21/2010US20100266574 Oligoribonucleotides and Methods of Use Thereof for Treatment of Fibrotic Conditions and Other Diseases
10/21/2010US20100266569 Prostatic acid phosphatase for the treatment of pain
10/21/2010US20100266564 Polyunsaturated Fatty Acid Synthase Nucleic Acid Molecules and Polypeptides, Compositions, and Methods of Making and Uses Thereof
10/21/2010US20100266556 Method for expanding hematopoietic stem cells using heterocyclic compound
10/21/2010US20100266551 Adeno-associated viral vectors for the expression of dysferlin
10/21/2010US20100266548 LPS-Responsive CHS1/Beige-Like Anchor Gene and Therapeutic Applications Thereof
10/21/2010US20100266547 Methods and compositions for treatment of interferon-resistant tumors
1 ... 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 ... 4023